Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion type Assertion NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_head.
- NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion wasGeneratedBy ECO_0000203 NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_provenance.
- NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion wasDerivedFrom befree-20150227 NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_provenance.
- NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion SIO_000772 21717286 NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_provenance.
- NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion evidence source_evidence_literature NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_provenance.
- NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_provenance.